About

PoC Capital seeks to invest in small, public life science companies whose product candidates have the opportunity to improve patient well-being. Strong management teams, clear mechanisms of action, and well-validated product development plans are key components of our investment thesis. PoC Capital specifically provides funding for companies to execute proof-of-concept clinical trials, which serve to unlock the value of development-stage assets through safety and efficacy validation.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 931 investors are based in Palo Alto, California, United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Stages
late-stage

Contact Information

in••••@poccap.com

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like PoC

Search Investors